What is Shanghai Kaibao Pharmaceutical CO.,Ltd's (300039.SZ) StockRank?

MoatMap's StockRank for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) is 68/100, with a Buy signal. This is a composite score combining Quality (68), Value (53), and Momentum (35) factor ranks across MoatMap's 19,000+ stock universe.

Does Shanghai Kaibao Pharmaceutical CO.,Ltd have an economic moat?

Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shanghai Kaibao Pharmaceutical CO.,Ltd a buy, hold, or sell?

MoatMap's current signal for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) is Buy, based on a StockRank of 68/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shanghai Kaibao Pharmaceutical CO.,Ltd in?

Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300039.SZ

BUYREMOVE

Shanghai Kaibao Pharmaceutical CO.,Ltd · Healthcare · China · $822M · Avg Vol: $7M/d

StockRank

P/E (TTM)

17.6x

ROE

5.8%

D/E

0.0x

Dividend %

2.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shanghai Kaibao is a traditional Chinese medicine manufacturer. It does not possess the global scale, regulatory validation, or advanced biologics capabilities of high-moat CDMOs.

COMPANY DESCRIPTION

Shanghai Kaibao Pharmaceutical Co., Ltd. researches, develops, and manufactures modern Chinese patent medicines, with a primary focus on respiratory and cardiovascular therapies. The company's flagship product, 'Tanreqing Injection,' is a widely prescribed, high-margin clinical treatment for acute respiratory tract infections in Chinese hospitals. Its proprietary manufacturing processes and extensive clinical validation support its strong brand equity and market position.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	165M	236M	218M	170M	1.0%
EPS	0.03	0.05	0.05	0.04	13.4%
Shares	1.0B	1.0B	1.0B	1.0B	0.0%
Debt	74M	81M	801,684	602,330	-79.9%
Equity	556M	596M	606M	653M	5.5%
Op CF	56M	57M	41M	34M	-15.1%
Inv CF	-42M	-29M	-5M	43M	—
Fin CF	-8M	-9M	-15M	-20M	—

PRICE (1M)-23.6%

SMA 50SMA 200

$0.66

RSI (14)

22.1

52W High

$1.01

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

7.0%63.3

ROE

5.8%58.4

GP/Assets

17.5%41.0

Op. Margin

24.4%87.9

FCF/Assets

2.6%59.9

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.00x97.7

Current Ratio

11.09x88.6

Value

P/E (TTM)

17.6x64.7

EV/EBITDA

12.1x35.8

P/FCF

307.2x30.2

P/B

1.0x79.1

P/S

4.5x44.4

Div Yield

2.9%68.2

Momentum

52W High %

65%48.8

RS 6M

-38%31.8

SMA 50/200

0.92x39.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—23.3

Q Growth

-23%22.0

FUNDAMENTALS

Market Cap

$822M

P/E (Forward)

17.0x

Gross Margin

80.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300039.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300039.SZ	Shanghai Kaibao Pharmaceutical CO.,Ltd(you)	$822M	68	BUY
300705.SZ	Hunan Jiudian Pharmaceutical Co., Ltd.	$869M	70	BUY
688566.SS	Jiangsu Jibeier Pharmaceutical Co., Ltd.	$741M	65	BUY
603439.SS	Guizhou Sanli Pharmaceutical Co.,Ltd	$984M	70	BUY
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD
002437.SZ	HARBIN GLORIA PHARMACEUTICALS Co., LTD	$975M	73	BUY
002550.SZ	Changzhou Qianhong Biopharma CO.,LTD	$1.2B	66	BUY
603207.SS	Shanghai Xiao Fang Pharmaceutical Co.,Ltd.	$556M	70	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) — Stock Score Summary

Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) has a MoatMap StockRank of 68/100 based on Quality (68/100), Value (53/100), and Momentum (35/100) factor scores. The current signal is BUY. Shanghai Kaibao is a traditional Chinese medicine manufacturer. It does not possess the global scale, regulatory validation, or advanced biologics capabilities of high-moat CDMOs.

Key Financial Metrics

Price	$0.66
Market Cap	$822M
P/E (TTM)	17.64
P/E (Forward)	16.96
Price/Book	0.99
Return on Equity	5.8%
Return on Invested Capital	7.0%
Debt/Equity	0.10
Gross Margin	80.3%
Operating Margin	24.4%
Revenue Growth	-29.3%
Dividend Yield	2.9%
Free Cash Flow	$3M

Shanghai Kaibao Pharmaceutical CO.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Kaibao Pharmaceutical CO.,Ltd’s (300039.SZ) StockRank?: MoatMap’s StockRank for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) is 68/100, with a Buy signal. It is a composite of Quality (68), Value (53), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Kaibao Pharmaceutical CO.,Ltd have an economic moat?: Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Kaibao Pharmaceutical CO.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) is Buy, based on a StockRank of 68/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Kaibao Pharmaceutical CO.,Ltd in?: Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).